Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data ; volume:18 ; number:1 ; day:6 ; month:2 ; year:2018 ; pages:1-9 ; date:12.2018
BMC cancer ; 18, Heft 1 (6.2.2018), 1-9, 12.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Ma, Qiufei
- Contributor
-
Shilkrut, Mark
Zhao, Zhongyun
Li, Minming
Batty, Nicolas
Barber, Beth
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4051-0
- URN
-
urn:nbn:de:1111-201804149708
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ma, Qiufei
- Shilkrut, Mark
- Zhao, Zhongyun
- Li, Minming
- Batty, Nicolas
- Barber, Beth
- SpringerLink (Online service)
Other Objects (12)
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Ipilimumab in patients with melanoma and autoimmune disease
Novel treatment paradigms for metastatic uveal melanoma
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis
Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma
Increased HOX C13 expression in metastatic melanoma progression
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Ipilimumab in patients with melanoma and autoimmune disease
Novel treatment paradigms for metastatic uveal melanoma
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis
Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma
Increased HOX C13 expression in metastatic melanoma progression
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Ipilimumab in patients with melanoma and autoimmune disease
Novel treatment paradigms for metastatic uveal melanoma
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis
Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma